NeurAxis, Inc. (NRXS)
6.21
+0.10
(+1.64%)
USD |
NYAM |
Nov 06, 10:30
NeurAxis Net Income (Quarterly) : -2.086M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.086M |
| March 31, 2026 | -1.761M |
| December 31, 2025 | -1.709M |
| September 30, 2025 | -2.123M |
| June 30, 2025 | -1.690M |
| March 31, 2025 | -2.279M |
| December 31, 2024 | -1.448M |
| September 30, 2024 | -1.755M |
| June 30, 2024 | -2.918M |
| Date | Value |
|---|---|
| March 31, 2024 | -2.121M |
| December 31, 2023 | -5.313M |
| September 30, 2023 | -8.625M |
| June 30, 2023 | -2.236M |
| March 31, 2023 | -2.173M |
| December 31, 2022 | -0.0136M |
| June 30, 2022 | -1.516M |
| March 31, 2022 | -0.5391M |
| December 31, 2021 | -0.8525M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Abbott Laboratories | 920.00M |
| AngioDynamics, Inc. | -7.097M |
| Alphatec Holdings, Inc. | -5.471M |
| AtriCure, Inc. | 4.064M |
| Baxter International, Inc. | 298.00M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.929M |
| Total Expenses (Quarterly) | 4.014M |
| EPS Diluted (Quarterly) | -0.1879 |
| Enterprise Value | 68.14M |
| Gross Profit Margin (Quarterly) | 85.87% |
| Profit Margin (Quarterly) | -108.1% |
| Earnings Yield | -12.56% |
| Normalized Earnings Yield | -12.52 |